These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 8112381)

  • 1. Stereoselective analysis of the disposition of tosufloxacin enantiomers in man.
    Minami R; Inotsume N; Nakamura C; Nakano M
    Eur J Clin Pharmacol; 1993; 45(5):489-91. PubMed ID: 8112381
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetics and tissue penetration of gemifloxacin following a single oral dose.
    Gee T; Andrews JM; Ashby JP; Marshall G; Wise R
    J Antimicrob Chemother; 2001 Apr; 47(4):431-4. PubMed ID: 11266415
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diffusion of tosufloxacin into prostatic tissue.
    Uchibayashi T; Hisazumi H; Kanayama J; Kumano K
    Chemotherapy; 1992; 38(3):150-4. PubMed ID: 1380905
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatobiliary elimination of trovafloxacin and metabolites following single oral doses in healthy volunteers.
    Melnik G; Schwesinger WH; Teng R; Dogolo LC; Vincent J
    Eur J Clin Microbiol Infect Dis; 1998 Jun; 17(6):424-6. PubMed ID: 9758286
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of aluminum hydroxide and famotidine on bioavailability of tosufloxacin in healthy volunteers.
    Minami R; Nakamura C; Inotsume N; Nakano M
    Antimicrob Agents Chemother; 1998 Feb; 42(2):453-5. PubMed ID: 9527806
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Single- and multiple-dose administration, dosing regimens, and pharmacokinetics of trovafloxacin and alatrofloxacin in humans.
    Vincent J; Dogolo L; Baris BA; Willavize SA; Teng R
    Eur J Clin Microbiol Infect Dis; 1998 Jun; 17(6):427-30. PubMed ID: 9758287
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An open, controlled, crossover study on the effects of cimetidine on the steady-state pharmacokinetics of trovafloxacin.
    Purkins L; Oliver SD; Willavize SA
    Eur J Clin Microbiol Infect Dis; 1998 Jun; 17(6):431-3. PubMed ID: 9758288
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetics and penetration into inflammatory fluid of trovafloxacin (CP-99,219).
    Wise R; Mortiboy D; Child J; Andrews JM
    Antimicrob Agents Chemother; 1996 Jan; 40(1):47-9. PubMed ID: 8787877
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetics and tolerability of gemifloxacin (SB-265805) after administration of single oral doses to healthy volunteers.
    Allen A; Bygate E; Oliver S; Johnson M; Ward C; Cheon AJ; Choo YS; Kim IC
    Antimicrob Agents Chemother; 2000 Jun; 44(6):1604-8. PubMed ID: 10817716
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetics and safety of trovafloxacin in healthy male volunteers following administration of single intravenous doses of the prodrug, alatrofloxacin.
    Vincent J; Venitz J; Teng R; Baris BA; Willavize SA; Polzer RJ; Friedman HL
    J Antimicrob Chemother; 1997 Jun; 39 Suppl B():75-80. PubMed ID: 9222074
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oral bioavailability of trovafloxacin with and without food in healthy volunteers.
    Teng R; Dogolo LC; Willavize SA; Friedman HL; Vincent J
    J Antimicrob Chemother; 1997 Jun; 39 Suppl B():87-92. PubMed ID: 9222076
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oral bioavailability and pharmacokinetics of trovafloxacin in patients with AIDS.
    Lacy MK; Nicolau DP; Nightingale CH; Geffken A; Teng R; Vincent J; Quintiliani R
    Antimicrob Agents Chemother; 1999 Dec; 43(12):3005-7. PubMed ID: 10582898
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of calcium carbonate on bioavailability of orally administered gemifloxacin.
    Pletz MW; Petzold P; Allen A; Burkhardt O; Lode H
    Antimicrob Agents Chemother; 2003 Jul; 47(7):2158-60. PubMed ID: 12821462
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetics of trovafloxacin (CP-99,219), a new quinolone, in rats, dogs, and monkeys.
    Teng R; Girard D; Gootz TD; Foulds G; Liston TE
    Antimicrob Agents Chemother; 1996 Mar; 40(3):561-6. PubMed ID: 8851571
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetics and safety assessment of tosufloxacin tosilate.
    Niki Y
    J Infect Chemother; 2002 Mar; 8(1):1-18. PubMed ID: 11957114
    [No Abstract]   [Full Text] [Related]  

  • 16. Pharmacokinetics of intravenous and oral enoxacin in healthy volunteers.
    Chang T; Black A; Dunky A; Wolf R; Sedman A; Latts J; Welling PG
    J Antimicrob Chemother; 1988 Feb; 21 Suppl B():49-56. PubMed ID: 3162901
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The disposition of gemifloxacin, a new fluoroquinolone antibiotic, in rats and dogs.
    Ramji JV; Austin NE; Boyle GW; Chalker MH; Duncan G; Fairless AJ; Hollis FJ; McDonnell DF; Musick TJ; Shardlow PC
    Drug Metab Dispos; 2001 Apr; 29(4 Pt 1):435-42. PubMed ID: 11259328
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetics of clinafloxacin enantiomers in humans.
    Humphrey GH; Shapiro MA; Randinitis EJ; Guttendorf RJ; Brodfuehrer JI
    J Clin Pharmacol; 1999 Nov; 39(11):1143-50. PubMed ID: 10579144
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis and biological properties of A-71497: a prodrug of tosufloxacin.
    Chu DT; Lico IM; Swanson RN; Marsh KC; Plattner JJ; Pernet AG
    Drugs Exp Clin Res; 1990; 16(9):435-43. PubMed ID: 2100244
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Excretion and metabolism of trovafloxacin in humans.
    Dalvie DK; Khosla N; Vincent J
    Drug Metab Dispos; 1997 Apr; 25(4):423-7. PubMed ID: 9107540
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.